Abstract
Coronavirus it’s an infectious disease which composed of single-stranded positive RNA & characterized by a spherical shape. COVID19 disease has spread worldwide from December 2019 to the present.
D-dimers are the breakdown products of cross-linked fibrin that are formed when plasmin cleaves fibrin and destroys blood clots. RBS (Random Blood Sugar) test, is the test which measures the amount of glucose in the blood.
This research, studies on those patient who have COVID-19(severe) with non-diabetic history, and determining if they got diabetes due to coronavirus or not. In the final analysis, Patient who had COVID-19 were having high D-dimer levels as well as RBS, and elevated fibrinogen levels, indicating activation of the coagulation pathway and thrombosis.
The prognostic role of hypercoagulability in COVID-19 patients is ambiguous. D-dimer, may be regarded as a global marker of hemostasis activation in COVID-19. The increase in the value of D-dimer is the most sensitive change in coagulation parameters in COVID-19 and indicate a greater risk for the development of thrombosis.
Blood glucose levels are linked to a higher risk of VTE (Venous Thromboembolism). Maximum blood glucose is a possible signal for VTE and can be used to identify patients who are more likely to develop the condition. In the final, patients resulted with high level of D-dimer and RBS, and some of them diagnosed with diabetes after being infected by SARS-COV-2.